At the National Association of Chain Drug Stores (NACDS) Annual Meeting, the NACDS Foundation announced the addition of seven first-time members to the NACDS Foundation Board of Directors. Each Director will serve a one-year term.
First-time NACDS Foundation Board of Directors include:
- Michael Bohling, Apotex Corp.
- Elizabeth Caton, The Procter & Gamble Company
- Philip Durocher, Colgate-Palmolive Company Inc.
- Anthony Provenzano, Albertsons Companies
- Rina Shah, Walgreen Co.
- William Simpson, DisposeRx Inc.
- Papatya Tankut, CVS Health
These seven individuals joined Steven C. Anderson, NACDS Foundation Chairman of the Board, in addition to the following veteran NACDS Foundation Board of Directors who were re-elected to serve a one-year term:
- Maureen Cavanaugh, Lannett Company, Inc.
- Brad Cochran, Cardinal Health
- Janice Cooney, Johnson & Johnson Consumer Health
- Brent Cotten, The Hershey Company
- Teri Coward, Teva Pharmaceuticals
- Lou Dallago, Pfizer Inc., Worldwide Pharmaceuticals
- Maureen Danielewicz, GSK
- Nikki Griffin, Lewis Drug
- Nimesh Jhaveri, McKesson Corporation
- Barbara Poremba, The Coca-Cola Company
- Bob Potter, Viatris
- George Rafferty, AmerisourceBergen Corporation
- Karen Staniforth, Rite Aid Corporation
- Richard Stephens, Costco Wholesale dba Costco Pharmacies
- Terry Thomas, Unilever
- Kristin Williams, Hy-Vee, Inc.
- Jackie Madsen, L’Oreal Paris, Division of L’Oreal USA
“The NACDS Foundation Board of Directors continue to offer transformational leadership and guidance as the Foundation supports programs and initiatives that prioritize the needs and experiences of all communities,” said NACDS Foundation President Sara Roszak. “We are thrilled to welcome these first-time and veteran Directors who will continue the Board’s commitment to advancing health equity, strengthening access and enhancing health outcomes.”
